Asterias Biotherapeutics Inc
(AST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 92 | N/A | N/A | N/A |
| TOTAL | $316 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,480 | N/A | N/A | N/A |
| Other Non-Current Assets | 54 | 0 | 0 | 0 |
| TOTAL | $1,535 | $N/A | $N/A | $N/A |
| Total Assets | $1,850 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 354 | 0 | 0 | 0 |
| Accrued Expenses | 235 | N/A | N/A | N/A |
| Other current liabilities | 6,392 | N/A | N/A | N/A |
| TOTAL | $6,981 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,981 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 30,499 | N/A | N/A | N/A |
| Retained earnings | -5,574 | N/A | N/A | N/A |
| Other shareholders' equity | -50 | 0 | 0 | 0 |
| TOTAL | $-5,130 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $1,850 | $0 | $0 | $0 |